Tumor-stromal interactions have been suggested to be a critical factor in both tumor invasion and tumor metastasis. Here, we examined the role of tumor-stromal interactions using co-cultures of prostate cancer (PC) cells derived from primary and metastatic tumors with primary or immortalized stromal
Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression
✍ Scribed by Anne Hansen Ree; Gunhild M. Mælandsmo; Øystein Fodstad
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 739 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0262-0898
No coin nor oath required. For personal study only.
✦ Synopsis
Regulation of two genes involved in tumor invasion, the matrix metalloproteinase (MMP)-I and the tissue inhibitor of MMP (TIMP)-I, by activators of protein kinase C (PKC) or protein kinase A (PKA) was studied in MCF-7 mammary adenocarcinoma cells. The basal mRNA expression was undetectable for MMP-1 and low for TIMP-I. Treatment of MCF-7 cells with the phorboi ester 12-O-tetradecanoylphorboi-13acetate (TPA) (100 nM) was associated with a high expression of MMP-1 mRNA, as well as an induction of the level of TIMP-1 mRNA (5-to 10-fold). In the presence of actinomycin D (AMD, 4.0 ~M), an inhibitor of transcription, these stimulatory effects of TPA were abolished. Similar responses were observed when protein synthesis was inhibited by cydoheximide (CHX, 50 ~M). In the presence of the cyclic AMP (cAMP) analogue N6-benzoyl (N6-Bzl)-cAMP (500 ~M), the MMP-1 mRNA was unaffected and still below the level of detection, whereas a non-significant increase (< 2-fold) in TIMP-1 mRNA was observed. The level of pS2 mRNA, of which the induction by TPA in MCF-7 cells is a primary transcriptional event, was up-regulated (10-to 15-fold) by TPA (100 nM), whereas a much weaker increase (2-to 3-fold) was observed by treatment with N6-Bzl-cAMP (500 ~M). Again, these stimulatory effects were counteracted by AMD (4.0 ~M) and CHX (50 ~M). These data suggest that activation of PKC but not of PKA may induce transcription of MMP-1 and TIMP-1, possibly by the synthesis of transcription factor(s), in transformed cells of epithelial origin.
📜 SIMILAR VOLUMES
We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these
## Abstract Matrix metalloproteinases (MMPs) degrade the extracellular matrix and are implicated in the pathogenesis of several neurological diseases. Secreted in proforms, the MMPs require activation. Tissue inhibitors of matrix metalloproteinases (TIMPs) regulate the activity of MMPs. We investig
## Abstract The production of matrix metalloproteinases (MMPs) by prostatic epithelial and/or neighboring stromal cells is considered to be a property that gives cells the capability to penetrate extracellular matrix barriers in normal or neoplastic growth. In order to examine the role of MMPs in t
Matrix metalloproteinase 2 (MMP-2) plays a crucial role in invasion and metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) was originally identified as an activator of MMP-2. Tissue inhibitor of MMP-2 (TIMP-2) was identified as an inhibitor of MMP-2 and MT1-MMP. However, TIMP-2 was report
## Background: The 5-year survival rate of patients with submucosal (sm) esophageal carcinoma continues to be much worse than that with intramucosal (m) lesions. the reasons are unclear, but matrix metalloproteinases (mmps) and membrane type matrix metalloproteinases (mt-mmps) are known to be invol